Immvira closes USD58m Series B led by Huagai Capital

2020-06-17
|
ChinaPEVC

Immvira officially announced the completion of a 58 million US dollars (400 million yuan) Series B financing round. The round was led by Huagai Capital, with participation from Apricot Capital, Cowin Capital, and GL Ventures, the leading investor in the previous round.


Proceeds from this round of financing will be used to advance clinical research on existing product pipeline, pre-clinical research and development of early-stage innovative drugs, and potential domestic and international strategic cooperation.


Immvira was established on May 18, 2015. It was jointly established by six scientists in the field of "oncolysis and immunity" of the United States. The company has carried out innovations in immunotherapy and targeted therapy of herpes oncolytic virus drug development, including five major product lines, covering all types of tumors.


In the meantime, the company successfully developed the freeze-drying technology of oncolytic virus products, which solved the problem of low temperature storage and transportation of products at -80℃.


Grace Zhou, Chairman and CEO of Immvira, said: "The completion of this financing round marks the important milestone for the company to enter the clinical research stage from the pre-clinical product development.”


RELATED ARTICLES

Eugenlight Technologies closes Series A of RMB tens of millions
2020-09-13
|
PEVC , Semiconductor , Electroinic

BPassword closes angel round led by Eagle Fund
2020-09-13
|
PEVC , Blockchain

Microtera Semiconductor closes Series A with RMB tens of millions
2020-09-13
|
PEVC , Semiconductor

Vertex Ventures completes new fund raising of RMB three bln
2020-09-13
|
PEVC , Technology , Semiconductor

Xiaoyinghe closes seed round of two mln yuan
2020-09-12
|
PEVC , Internet

Orthopedic AI company Changmugu closes Series A+ of RMB tens of mlns
2020-09-12
|
PEVC , Medical care

D2M Biotherapeutics completes $10 million Pre-A round of financing
2020-08-23
|
PEVC , Pharmaceutical , Biotech

3D vision company UTECH closes multimillion-yuan financing round
2020-08-09
|
PEVC , Manufacturing , 3D machine

MicuRx Pharmaceuticals closes RMB300m Series D
2020-08-07
|
PEVC , Pharmaceutical

Antengene Corporation closes USD97m Series C round for new drug
2020-07-23
|
Medical care , Pharmaceutical , Biotech , PEVC
China SDG